Telemonitoring of uncontrolled hypertensio

Not Applicable

• Conditions: Patients with hypertension, with a systolic blood pressure > 140 mmHg; Circulatory System; Essential (primary) hypertension

• Registration Number: ISRCTN10969896
• Lead Sponsor: eiden University Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-01
• Last Update Posted: 29 July 2019
• Study Completion: 2020-01-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

1. Patients with hypertension, with a systolic blood pressure > 140 mmHg
2. Patients who are willing to measure their blood pressure at home before and during 12 months of treatment
3. Access to the internet at home and ability to use it

Exclusion Criteria

1. Serious psychological problems that may interfere with compliance or reliability of the measurements
2. Relevant somatic or psychiatric co-morbidity that interferes with the study
3. Systolic blood pressure >200 mmHg
4. Progressive signs of organ damage
5. Already using a home blood pressure device
6. Unable to understand the Dutch interface of PatientCoach

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of patients with controlled OBP (i.e., <140/90 mm Hg or <130/80 mm Hg if diabetes or chronic kidney disease is present) at 6 and 12 months

Secondary Outcome Measures

Name	Time	Method
<br> 1. Self-management skills and health education impact are measured by the Health Education Impact Questionnaire at baseline and 12 months<br> 2. Motivation/user acceptance are measured by the Technology Acceptance Questionnaire at baseline, 4 and 12 months<br> 3. Patient utilities are measured by the EQ-5D-3L at baseline, 4 and 12 months<br> 4. Therapy adherence is measured by the Medication Adherence Rating Scale (MARS)) at baseline, 4 and 12 months<br>